ALK-Abelló A/S

CPSE:ALK B Stock Report

Market Cap: DKK 49.5b

ALK-Abelló Valuation

Is ALK B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of ALK B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: ALK B (DKK223.4) is trading below our estimate of future cash flow value (DKK282.91)

Significantly Below Future Cash Flow Value: ALK B is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALK B?

Key metric: As ALK B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ALK B. This is calculated by dividing ALK B's market cap by their current earnings.
What is ALK B's PE Ratio?
PE Ratio41.4x
EarningsDKK 1.20b
Market CapDKK 49.45b

Price to Earnings Ratio vs Peers

How does ALK B's PE Ratio compare to its peers?

The above table shows the PE ratio for ALK B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.2x
HLUN B H. Lundbeck
13.5x-1.83%DKK 41.6b
NOVO B Novo Nordisk
11x3.01%DKK 1.1t
GMAB Genmab
17.4x17.83%DKK 109.0b
BAVA Bavarian Nordic
10.9x3.66%DKK 15.2b
ALK B ALK-Abelló
41.4x14.88%DKK 49.5b

Price-To-Earnings vs Peers: ALK B is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the peer average (13.2x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does ALK B's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
ALK B 41.4xIndustry Avg. 22.0xNo. of Companies9PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ALK B is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the European Pharmaceuticals industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is ALK B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALK B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio41.4x
Fair PE Ratio16.3x

Price-To-Earnings vs Fair Ratio: ALK B is expensive based on its Price-To-Earnings Ratio (41.4x) compared to the estimated Fair Price-To-Earnings Ratio (16.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALK B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentDKK 224.00
DKK 263.33
+17.56%
4.48%DKK 280.00DKK 255.00n/a3
Feb ’27DKK 207.60
DKK 214.00
+3.08%
13.55%DKK 243.00DKK 185.00n/a2
Jan ’27DKK 228.60
DKK 219.33
-4.05%
11.33%DKK 243.00DKK 185.00n/a3
Dec ’26DKK 233.60
DKK 219.33
-6.11%
11.33%DKK 243.00DKK 185.00n/a3
Nov ’26DKK 213.40
DKK 193.00
-9.56%
6.99%DKK 212.00DKK 182.00n/a3
Oct ’26DKK 208.00
DKK 193.00
-7.21%
6.99%DKK 212.00DKK 182.00n/a3
Sep ’26DKK 204.60
DKK 193.00
-5.67%
6.99%DKK 212.00DKK 182.00n/a3
Aug ’26DKK 189.00
DKK 182.25
-3.57%
3.06%DKK 190.00DKK 176.00n/a4
Jul ’26DKK 187.80
DKK 182.25
-2.96%
3.06%DKK 190.00DKK 176.00n/a4
Jun ’26DKK 177.90
DKK 182.25
+2.45%
3.06%DKK 190.00DKK 176.00n/a4
May ’26DKK 153.20
DKK 180.75
+17.98%
3.88%DKK 190.00DKK 173.00n/a4
Apr ’26DKK 141.00
DKK 181.25
+28.55%
3.67%DKK 190.00DKK 173.00DKK 205.804
Mar ’26DKK 153.10
DKK 181.25
+18.39%
3.67%DKK 190.00DKK 173.00DKK 220.404
Feb ’26DKK 162.80
DKK 180.75
+11.03%
3.88%DKK 190.00DKK 173.00DKK 207.604
Jan ’26DKK 159.10
DKK 172.75
+8.58%
7.62%DKK 190.00DKK 153.00DKK 228.604
Dec ’25DKK 162.00
DKK 181.20
+11.85%
11.37%DKK 215.00DKK 153.00DKK 233.605
Nov ’25DKK 163.60
DKK 177.00
+8.19%
9.28%DKK 200.00DKK 153.00DKK 213.405
Oct ’25DKK 171.10
DKK 177.00
+3.45%
9.28%DKK 200.00DKK 153.00DKK 208.005
Sep ’25DKK 179.00
DKK 168.60
-5.81%
15.35%DKK 200.00DKK 128.00DKK 204.605
Aug ’25DKK 156.50
DKK 155.40
-0.70%
11.51%DKK 180.00DKK 128.00DKK 189.005
Jul ’25DKK 151.10
DKK 155.40
+2.85%
11.51%DKK 180.00DKK 128.00DKK 187.805
Jun ’25DKK 152.60
DKK 155.00
+1.57%
11.40%DKK 175.00DKK 126.00DKK 177.905
May ’25DKK 131.20
DKK 132.75
+1.18%
7.63%DKK 145.00DKK 120.00DKK 153.204
Apr ’25DKK 124.10
DKK 125.00
+0.73%
15.03%DKK 140.00DKK 94.00DKK 141.004
DKK 263.33
Fair Value
15.2% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/21 16:57
End of Day Share Price 2026/04/21 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ALK-Abelló A/S is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Jesper IlsoeCarnegie Investment Bank AB
Jesper IngildsenDNB Carnegie